High Dose Therapy and Autologous Stem Cell Transplantation in Follicular non-Hodgkin's Lymphoma

References

• Horning S. J., Rosenberg S. A. The natural history of initially untreated low-grade non-Hodgkin's lymphoma. N. Engl. J. Med. 1984; 311: 1471
   PubMed Web of Science ®Google Scholar
• Gallagher C. J., Gregory W. M., Jones A. E., Stansfeld A. G., Richards M. A., Dhaliwal H. S., Malpas J. S., Lister T. A. Follicular lymphoma: Prognostic factors for response and survival. J. Clin. Oncol 1986; 4: 1470
   PubMed Web of Science ®Google Scholar
• Johnson P., Rohatiner A., Whelan J., Price C., Love S., Lim J., Mattews J., Norton A., Amess J., Lister T. Patterns of survival in patients with recurrent follicualr lymphoma: a 20 year study froma single center. J Clin Oncol 1995; 13: 140
   PubMed Web of Science ®Google Scholar
• Philip T., Guglielmi C., Hagenbeek A., Somers R., Van der Lelie H., Bron D., Sonneveld P., Gisselbrecht C., Cahn J., Harousseau J., Coiffier B., Biron P., Mandelli F., Chauvin F. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. N Eng J Med 1995; 333: 1540
   PubMed Web of Science ®Google Scholar
• Young R. C., Longo D. L., Glatstein E., Ihde D. C., Jaffe E. S., DeVita V. T. The treatment of indolent lymphomas: Watchful waiting V aggressive combined modality treament. Sem. Hematol. 1988; 25: 11
   PubMed Web of Science ®Google Scholar
• Schouten H. C., Bierman P. J., Vaughan W. P., Kessinger A., Vose J. M., Weisenburger D. D., Armitage J. O. Autologous bone marrow transplantation in follicular non-Hodgkin's lymphoma before and after histologic transformation. Blood 1989; 74: 2579
   PubMed Web of Science ®Google Scholar
• Freedman A. S., Ritz J., Neuberg D., Anderson K. C., Rabinowe S. N., Mauch P., Takvorian T., Soiffer R., Blake K., Yeap B., Coral F., Helfin L., Nadler L. M. Autologous bone marrow transplantation in 69 patients with a history of low grade B-cell non-Hodgkin's lymphoma. Blood 1991; 77: 2524
   PubMed Web of Science ®Google Scholar
• Vose J., Bierman P., Armitage J. High dose chemotherapy with stem cell rescue for the treatment of follicular low grade non-Hodgkin's lymphoma. Autologous Bone Marrow Transplantation. Proceedings of the Fifth International Symposium, V. 1991; 479
   Google Scholar
• Rohatiner A., Johnson P., Price C., Arnott S. J., Amess J., Norton A., Dorey E., Adams K., Whelan J., Matthews J., MacCallum P., Oza A., Lister T. Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for recurrent follicular lymphoma. J Clin Oncol 1994; 12: 1177
   PubMed Web of Science ®Google Scholar
• Colombat P., Donadio D., Fouillard L., Milpied N., Tilly H., Pico J., Abrgrall J., Coiffier B., Herbrecht R., Philip T. Value of autologous bone marrow transplantation in follicular lymphoma: A France Autogreffe retrospective study of 42 patients. Bone Marrow Transplant 1994; 13: 157
   PubMed Web of Science ®Google Scholar
• Haas R., Murea S., Moos M., Hohaus S., Goldschmidt H., Hunstein W. High-dose therapy with peripheral blood stem cell transplantation in low-grade non-Hodgkin's lymphomas. Blood 1996; 88: 120
   Google Scholar
• Haas R., Moos M., Karcher A., Mohle R., Witt B., Goldschmidt H., Fruhauf S., Flentje M., Wannenmacher M., Hunstein W. Sequential high dose therapy with peripheral blood progenitor cell support in low grade non-Hodgkin's lymphoma. J Clin Oncol 1994; 12: 1685
   PubMed Web of Science ®Google Scholar
• Williams C., Goldstone A., Pearce R., Philip T., Hartmann O., Colombat P., Santini G., Foulard L., Gorin N. Purging of bone marrow in autologous bone marrow transplantation for non-Hodgkin's lymphoma: a case matched comparison with unpurged cases by the European Blood and Marrow Transplant Lymphoma Registry. J Clin Oncol 1996; 14: 2454
   PubMed Web of Science ®Google Scholar
• Bastion Y., Brice P., Haioun C., Sonet A., Salles G., Marolleau J., Espinouse D., Reyes F., Gisselbrecht C., Coiffier B. Intensive therapy with peripheral blood progenitor cell transplantation in 60 patients with poor-prognosis follicular lymphoma. Blood 1995; 86: 3257
   PubMed Web of Science ®Google Scholar
• Bierman P., Vose J., Anderson J., Bishop M., Kessinger A., Armitage J. High-dose therapy with autologous hematopoietic rescue for follicular low-grade non-Hodgkin's lymphoma. J Clin Oncol 1997; 15: 445
   PubMed Web of Science ®Google Scholar
• Acker B., Hoppe R. T., Colby T. V., Cox R. S., Kaplan H. S., Rosenberg S. A. Histologic Conversion in the non-Hodgkin's lymphomas. J. Clin. Oncol. 1983; 1: 11
   PubMed Web of Science ®Google Scholar
• Gribben J. G., Freedman A. S., Neuberg D., Roy D. C., Blake K. W., Woo S. D., Grossbard M. L., Rabinowe S. N., Coral F., Freeman G. J., et al. Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. N Engl J Med 1991; 325: 1525
   PubMed Web of Science ®Google Scholar
• Berinstein N. L., Jamal H. H., Kuzniar B., Klock R. J., Reis M. D. Sensitive and reproducible detection of occult disease in patients with follicular lymphoma by PCR amplification of t(14; 18) both pre- and post-treatment. Leukemia 1993; 7: 113
   PubMed Web of Science ®Google Scholar
• Hickish T. F., Purvies H., Mansi J., Soukop M., Cunningham D. Molecular monitoring of low grade non-Hodgkin's lymphoma by gene amplification. Br J Cancer 1991; 64: 1161
   PubMed Web of Science ®Google Scholar
• Lambrechts A. C., Hupkes P. E., Dorssers L. C. J., van'l Veer M. B. Clinical significance of translocation t(14;18) positive cells in the circulation of patients with stage III or IV follicular non-Hodgkin's lymphoma during first remission. J Clin Oncol 1994; 12: 1541
   PubMed Web of Science ®Google Scholar
• Brenner M., Rill D., Moen R., Krance R., Mirro J., Anderson W., Ihle J. Gene-marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet 1993; 341: 85
   PubMed Web of Science ®Google Scholar
• Kessinger A., Armitage J. O., Smith D. M., Landmark J. D., Bierman P. J., Weisenburger D. D. High-dose therapy and autologous peripheral blood stem cell transplantation for patients with lymphoma. Blood 1989; 74: 1260
   PubMed Web of Science ®Google Scholar
• Van Besien K., Khouri I., Giralt S., McCarthy P., Mehra R., Andersson B., Przepiorka D., Gajewski J., Bellare N., Nath R., Romaguera J., McLaughlin P., Korbling M., Deisseroth A., Cabanillas F., Champlin R. Allogeneic bone marrow transplantation for refractory and recurrent low-grade lymphoma: the case for aggressive management. J Clin Oncol 1995; 13: 1096
   PubMed Web of Science ®Google Scholar
• Soiffer R., Neuberg D., Freedman A., Alyea E., Fisher D., Bartlett-Pandite L., Gribben J., Schlossman R., Freeman A., Anderson K., Nadler L., Ritz J. CD6 depleted allogeneic and syngeneic bone marrow transplantation for non-Hodgkin's lymphoma. Blood 1996; 88: 683
   Google Scholar
• Jones R., Ambinder R., Piantadosi S., Santos G. Evidence for a graft-versus-lymphoma effect associated with allogeneic bone marrow transplantation. Blood 1991; 77: 649
   PubMed Web of Science ®Google Scholar
• Ratanatharathorn V., Uberti J., Karanes C., Abella E., Lum L., Momin F., Cummings G., Sensenbrenner L. Prospective comparative trial of autologous versus allogeneic bone marrow transplantation in patients with non-Hodgkin's lymphoma. Blood 1994; 84: 1050
   PubMed Web of Science ®Google Scholar
• Freedman A., Gribben J., Neuberg D., Mauch P., Soiffer R., Anderson K., Fisher D., Schlossman R., Kroon M., Ritz J., Nadler L. Long term prolongation of disease free and overall survival following autologous bone marrow transplantation in patients with advanced relapsed follicular lymphoma. Proc Am Soc Clin Oncol
   Google Scholar
• Thomas E. D., Clift R. A. Indications for marrow transplantation in chronic myelogenous leukemia. Blood 1989; 73: 861
   PubMed Web of Science ®Google Scholar
• Freedman A., Gribben J., Neuberg D., Mauch P., Soiffer R., Anderson K., Pandite L., Robertson M., Kroon M., Ritz J., Nadler L. High dose therapy and autologous bone marrow transplantation in patients with follicular lymphoma during first remission. Blood 1996; 88: 2780
   PubMed Web of Science ®Google Scholar
• Gribben J., Freedman A., Woo S., Blake K., Shu R. G. F., Longtine J., Pinkus G., Nadler L. All advanced stage non-Hodgkin's lymphomas with a polymerase chain reaction amplifiable breakpoint of bcl-2 have residual cells containing the bcl-2 rearrangement at evaluation and after treatment. Blood 1991; 78: 3275
   PubMed Web of Science ®Google Scholar
• Tarella C., Corradini P., Caracciolo D., Astolfi M., Castellino C., Gavarotti P. High dose chemotherapy as unfront treatment in 35 patients with indolent lymphoma induces a high rate of durable clinical and molecular remission. Blood 1996; 88: 121
   Google Scholar
• Hsu F., Benike C., Fagnoni F., Liles T., Czerwinski D., Taidi B., Engleman E., Levy R. Vaccination of patients with B-cell lymphoma using autologous antigen pulsed dendritic cells. Nature Med 1996; 2: 52
   PubMed Web of Science ®Google Scholar
• Schultze J., Cardoso A., Freeman G., Seamon M., Daley J., Pinkus G., Gribben J., Nadler L. Follicular lymphomas can be induced to present alloantigen efficiently: A conceptual model to improve their tumor immunogenicity. Proc Natl Acad Sci USA. 1995; 92: 8200
   PubMed Web of Science ®Google Scholar
• Grossbard M., Press O., Appelbaum F., Bernstein I., Nadler L. Monoclonal antibody-based therapies of leukemia and lymphoma. Blood 1992; 80: 863
   PubMed Web of Science ®Google Scholar
• Press O., Eary J., Appelbaum F., Martin P., Badger C., Nelp W., Glenn S., Butchko G., Fisher D., Porter B., Matthews D., Fisher L., Bernstein I. Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support. N Engl J Med 1993; 329: 1219
   PubMed Web of Science ®Google Scholar
• Kaminski M., Zasadny K., Francis I., Milik A., Ross C., Moon S., Crawford S., Burgess J., Petry N., Butchko G., Glenn S., Wahl R. Radioimmunotherapy of B-cell lymphoma with Anti-B1 (Anti-CD20) antibody. JV Engl J Med 1993; 329: 459
   PubMed Web of Science ®Google Scholar
• Press O., Eary J., Applebaum F., Martin P., Nelp W., Glenn S., Fisher D., Porter B., Matthews D., Gooley T., Bernstein I. Phase II trial of 131-B1 (anti-Cd20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomas. Lancet 1995; 346: 336
   PubMed Web of Science ®Google Scholar
• Kaminski M., Zasadny K., Francis I., Fenner M., Ross C., Milik A., Estes J., Tuck M., Regan D., Fisher S., Glenn S., Wahl R. Iodine-131-anti-B1 radioimmunotherapy for B-cell lymphoma. J Clin Oncol 1996; 14: 1974
   PubMed Web of Science ®Google Scholar